Eradican is an organization poised to become the gold standard in new therapeutic potential for the metastatic breast cancer community by developing advanced nanoparticle technologies and creating a new market category for emerging Nano-therapeutics. Our core team consists of dedicated scientists and business leaders who are committed to launching a company that is successful in product commercialization and impacting patients lives. The Eradican mentorship team consists of industry experts and business development professionals who have over 60 years of biotech startup experience and have collectively raised over $150M in capital.
The Nanotechnology Startup Challenge in Cancer leadership team has been incredibly supportive throughout the competition and has consistently guided us through various obstacles. As with any therapeutic, Eradican's gold nanoparticle technology will need to undergo preclinical and clinical trials to prove safety and efficacy as a therapy. We've crafted several complementary ideas for product commercialization and further research that would enable us to generate profit within the first year of launching.
The Nanotechnology Startup Challenge in Cancer has been a very positive learning experience, especially for a cross-functional team to learn from one another and industry professionals. We look forward to launching Eradican in the coming weeks and developing a successful company for Nano-therapeutics and metastatic breast cancer.
Written by Krystle Karoscik : Team Eradican
The Nanotechnology Startup Challenge in Cancer leadership team has been incredibly supportive throughout the competition and has consistently guided us through various obstacles. As with any therapeutic, Eradican's gold nanoparticle technology will need to undergo preclinical and clinical trials to prove safety and efficacy as a therapy. We've crafted several complementary ideas for product commercialization and further research that would enable us to generate profit within the first year of launching.
The Nanotechnology Startup Challenge in Cancer has been a very positive learning experience, especially for a cross-functional team to learn from one another and industry professionals. We look forward to launching Eradican in the coming weeks and developing a successful company for Nano-therapeutics and metastatic breast cancer.
Written by Krystle Karoscik : Team Eradican
RSS Feed
